Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Mandonnet

Showing results (131-140 of 183) with videos related to

Pageof 19
Sort By:
Neuro-Oncology Practice|March 9, 2026
Preserved IDH mutation and methylation class in vorasidenib nonresponders: A report of 2 casesMehdi Touat, Jacqueline Lehmann-Che, Salah Eddine O Kacimi, et al.
Acta Neurochirurgica|March 5, 2020
Anesthesia management for low-grade glioma awake surgery: a European Low-Grade Glioma Network surveyJeremy Arzoine, Charlotte Levé, Antonio Pérez-Hick, et al.
Annals of Neurology|April 1, 2003
Continuous growth of mean tumor diameter in a subset of grade II gliomasEmmanuel Mandonnet, Jean-Yves Delattre, Marie-Laure Tanguy, et al.
Plos One|July 10, 2015
IDH-Mutation Is a Weak Predictor of Long-Term Survival in Glioblastoma PatientsAymeric Amelot, Patricia De Cremoux, Véronique Quillien, et al.
Journal of Neurosurgery|April 2, 2021
Endoscope-assisted far-lateral transcondylar approach for craniocervical junction chordomas: a retrospective case series and cadaveric dissectionArianna Fava, Paolo di Russo, Valentina Tardivo, et al.
Annals of Neurology|October 30, 2010
Natural history of incidental World Health Organization grade II gliomasJohan Pallud, Denys Fontaine, Hugues Duffau, et al.
Journal of Neuro-Oncology|February 22, 2015
Evolution of the Karnosky Performance Status throughout life in glioblastoma patientsAdama Sacko, Miao-Miao Hou, Michael Temgoua, et al.
Neurosurgery|January 27, 2015
Initial experience using awake surgery for glioma: oncological, functional, and employment outcomes in a consecutive series of 25 casesEmmanuel Mandonnet, Philip De Witt Hamer, Isabelle Poisson, et al.
Neurosurgery|May 14, 2021
Tumor Growth Rate as a New Predictor of Progression-Free Survival After Chordoma SurgeryThibault Passeri, Paolo di Russo, Pierre-Olivier Champagne, et al.
Journal of Neuro-Oncology|March 13, 2013
Neoadjuvant chemotherapy may optimize the extent of resection of World Health Organization grade II gliomas: a case series of 17 patientsMarie Blonski, Johan Pallud, Catherine Gozé, et al.
Pageof 19

Showing results (131-140 of 183) with videos related to

Sort By:
Pageof 19
Neuro-Oncology Practice|March 9, 2026
Preserved IDH mutation and methylation class in vorasidenib nonresponders: A report of 2 casesMehdi Touat, Jacqueline Lehmann-Che, Salah Eddine O Kacimi, et al.
Acta Neurochirurgica|March 5, 2020
Anesthesia management for low-grade glioma awake surgery: a European Low-Grade Glioma Network surveyJeremy Arzoine, Charlotte Levé, Antonio Pérez-Hick, et al.
Annals of Neurology|April 1, 2003
Continuous growth of mean tumor diameter in a subset of grade II gliomasEmmanuel Mandonnet, Jean-Yves Delattre, Marie-Laure Tanguy, et al.
Plos One|July 10, 2015
IDH-Mutation Is a Weak Predictor of Long-Term Survival in Glioblastoma PatientsAymeric Amelot, Patricia De Cremoux, Véronique Quillien, et al.
Journal of Neurosurgery|April 2, 2021
Endoscope-assisted far-lateral transcondylar approach for craniocervical junction chordomas: a retrospective case series and cadaveric dissectionArianna Fava, Paolo di Russo, Valentina Tardivo, et al.
Annals of Neurology|October 30, 2010
Natural history of incidental World Health Organization grade II gliomasJohan Pallud, Denys Fontaine, Hugues Duffau, et al.
Journal of Neuro-Oncology|February 22, 2015
Evolution of the Karnosky Performance Status throughout life in glioblastoma patientsAdama Sacko, Miao-Miao Hou, Michael Temgoua, et al.
Neurosurgery|January 27, 2015
Initial experience using awake surgery for glioma: oncological, functional, and employment outcomes in a consecutive series of 25 casesEmmanuel Mandonnet, Philip De Witt Hamer, Isabelle Poisson, et al.
Neurosurgery|May 14, 2021
Tumor Growth Rate as a New Predictor of Progression-Free Survival After Chordoma SurgeryThibault Passeri, Paolo di Russo, Pierre-Olivier Champagne, et al.
Journal of Neuro-Oncology|March 13, 2013
Neoadjuvant chemotherapy may optimize the extent of resection of World Health Organization grade II gliomas: a case series of 17 patientsMarie Blonski, Johan Pallud, Catherine Gozé, et al.
Pageof 19